Insulin glargine and lixisenatide and Zoledronic Acid Injection Concentrate
Determining the interaction of Insulin glargine and lixisenatide and Zoledronic Acid Injection Concentrate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin Glargine and Lixisenatide
Generic Name: zoledronic acid
Brand name: Reclast, Zometa, Zometa Concentrate, Aclasta
Synonyms: Zoledronic acid, Zoledronic Acid
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide-Zoledronic acid Intravenous
- Insulin glargine and lixisenatide-Zoledronic Acid IV
- Insulin glargine and lixisenatide-Zolgensma
- Insulin glargine and lixisenatide-Zolinza
- Insulin glargine and lixisenatide-Zolmitriptan
- Insulin glargine and lixisenatide-Zolmitriptan nasal
- Zoledronic Acid Injection Concentrate-Insulin glargine and lixisenatide Subcutaneous
- Zoledronic Acid Injection Concentrate-Insulin glargine, recombinant Subcutaneous
- Zoledronic Acid Injection Concentrate-Insulin glulisine
- Zoledronic Acid Injection Concentrate-Insulin Glulisine (Cartridges and Pens)
- Zoledronic Acid Injection Concentrate-Insulin Glulisine (Vials)
- Zoledronic Acid Injection Concentrate-Insulin glulisine Subcutaneous